BCT.TO
Briacell Therapeutics Corp
Price:  
0.95 
CAD
Volume:  
11,100.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCT.TO Intrinsic Value

-169.70 %
Upside

As of 2024-12-15, the Intrinsic Value of Briacell Therapeutics Corp (BCT.TO) is -0.66 CAD. This BCT.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.95 CAD, the upside of Briacell Therapeutics Corp is -169.70%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.95 CAD
Stock Price
-0.66 CAD
Intrinsic Value
Intrinsic Value Details

BCT.TO Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -0.66 - -0.66 -0.66 -169.70%
P/E 0.95 - 0.95 0.95 0.4%
DDM - Stable (0.80) - (2.32) (1.56) -264.1%
DDM - Multi (0.64) - (1.54) (0.92) -196.3%

BCT.TO Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 34.37
Beta 1.12
Outstanding shares (mil) 36.18
Enterprise Value (mil) 33.51
Market risk premium 5.10%
Cost of Equity 12.39%
Cost of Debt 5.00%
WACC 8.04%